| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |